Mo, F. http://orcid.org/0000-0002-8469-7567
Meletti, S.
Belcastro, V.
Quadri, S.
Napolitano, M.
Bello, L.
Dainese, F.
Scarpelli, M.
Florindo, I.
Mascia, A.
Pauletto, G.
Bruno, F.
Pellerino, A.
Giovannini, G.
Polosa, M.
Sessa, M.
Conti Nibali, M.
Di Gennaro, G.
Gigli, G. L.
Pisanello, A.
Cavallieri, F.
Rudà , R.
Article History
Received: 21 January 2022
Accepted: 24 March 2022
First Online: 9 April 2022
Declarations
:
: Mo F., Meletti S., Belcastro V., Quadri S., Napolitano M., Bello L., Dainese F., Scarpelli M., Florindo I., Mascia A., Pauletto G., Bruno F., Pellerino A., Giovannini G., Polosa M., Sessa M., Conti Nibali M., Gigli G.L., Pisanello A., Cavallieri F.: did not declare conflicts of interests. Di Gennaro G. joined advisory boards and pharmaceutical industry-sponsored symposia for EISAI, UCB, LivaNova, Arvelle. Rudà R. joined Advisory Boards and received grants from UCB, Mundipharma, Novocure and Bayer.
: Informed consent was obtained from all individual participants included in the study.